Care and disease management programs and tools are ubiquitous. A study in the Journal of General Internal Medicine considers whether ones directed by health plans or providers have greater success, if any. (JGIM Article) In theory, provider-operated disease management might have more success, since it is inherently integrated with primary care. The study compared in one health plan over 2010 to 2012, disease management programs operated by the plan’s staff for congestive heart failure, chronic obstructive pulmonary disease, coronary heart disease, diabetes and asthma, versus those operated by four physician groups consisting of 31 primary care practices and funded by the health plan. The programs did not have identical features, but were broadly similar. A pre-post design was used to analyze impacts. Outcomes included cholesterol levels, weight management, blood pressure, and blood sugar control. Data from around 4000 patients was included in the analysis. There was modest improvement in most outcome measures for both groups. The provider-directed care management programs did somewhat better on some measures and the health plan programs did somewhat better on others, but none of the differences reached statistical significance. Both programs accomplished getting some additional patients engaged in a program. Many of the patients, although suffering from one of the chronic diseases, already had outcome measures that were within goals, making further improvement difficult. There was a savings in overall health expenditures among both groups, but these savings were not compared to the costs of the programs. The general lack of substantial improvement in outcome measures is not encouraging for disease management programs generally, and is consistent with some other research, but it is good to find that both health plan and provider-operated disease management programs appear to have some effectiveness.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Now here is a tale from the glory days of epidemic investing, as the Feds pumped trillions into the economy and a lot of it went to investing, some to...
January 10, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace